diagnosi
respiratori
viru
infect
evolv
substanti
recent
year
emerg
new
pathogen
develop
novel
detect
method
recent
advanc
improv
sensit
turnaround
time
diagnost
test
respiratori
virus
also
rais
import
issu
cost
clinic
signific
detect
multipl
virus
singl
specimen
molecular
method
articl
review
recent
advanc
specimen
collect
detect
method
diagnosi
respiratori
viru
infect
discuss
perform
characterist
limit
method
respiratori
viru
infect
major
impact
health
acut
respiratori
ill
mostli
caus
virus
common
ill
experienc
otherwis
healthi
children
adult
worldwid
upper
respiratori
tract
infect
uri
common
cold
exceedingli
preval
infant
young
children
continu
common
older
children
adult
infant
young
children
may
episod
cold
per
year
attend
daycar
center
may
mani
episod
per
year
uri
lead
complic
acut
otiti
media
asthma
exacerb
lower
respiratori
tract
infect
lri
lri
pneumonia
bronchiti
bronchiol
occur
much
less
frequent
caus
higher
morbid
mortal
thu
associ
high
impact
greater
healthcar
cost
approxim
one
third
children
develop
lri
first
year
life
lri
incid
decreas
earli
school
year
preadolesc
healthi
adult
year
common
respiratori
virus
includ
influenza
b
respiratori
syncyti
viru
b
parainfluenza
viru
type
adenoviru
rhinoviru
human
metapneumoviru
coronaviru
type
less
common
respiratori
virus
includ
parainfluenza
viru
type
influenza
viru
c
specif
type
enterovirus
signific
recent
discov
virus
human
bocaviru
coronaviru
yet
elucid
clinic
present
respiratori
viru
infect
overlap
among
caus
variou
virus
addit
clinic
manifest
may
mimic
diseas
caus
bacteria
therefor
antibiot
often
use
infect
unnecessarili
furthermor
lri
often
requir
hospit
manag
intraven
antibiot
symptomat
support
treatment
specif
antivir
treatment
respiratori
viru
infect
avail
influenza
respiratori
viral
diagnosi
integr
part
patient
manag
accur
diagnosi
specif
respiratori
viru
infect
improv
knowledg
diseas
patient
also
affect
patient
manag
help
prevent
secondari
spread
infect
rapid
viral
diagnosi
may
result
discontinu
unnecessari
antibiot
initi
antivir
drug
influenza
reduct
cost
relat
reduct
unnecessari
investig
shorten
hospit
stay
paper
describ
uptod
inform
laboratori
method
present
avail
diagnost
virolog
laboratori
upcom
detect
respiratori
virus
perhap
one
signific
advanc
detect
respiratori
virus
recent
introduct
novel
swab
type
flock
swab
flock
swab
consist
nylon
fiber
perpendicular
swab
shaft
unlik
standard
woven
rayon
swab
trap
sampl
materi
fiber
flock
swab
act
like
brush
collect
respiratori
epitheli
cell
effici
releas
transport
medium
studi
compar
nasal
flock
swab
nasal
aspir
children
show
sensit
flock
swab
least
equival
detect
varieti
respiratori
virus
similar
studi
compar
flock
swab
woven
rayon
swab
adult
patient
need
anoth
type
novel
swab
materi
polyurethan
foam
recent
studi
demonstr
polyurethan
foam
swab
anterior
nare
perform
better
flock
swab
detect
influenza
virus
children
rapid
antigen
test
tradit
nasal
wash
aspir
consid
superior
swab
specimen
isol
respiratori
virus
cell
cultur
detect
viral
antigen
immunoassay
howev
contemporari
diagnost
assay
use
flock
swab
superior
may
mitig
one
recent
studi
nasopharyng
nasal
swab
found
superior
nasal
wash
detect
influenza
virus
rapid
antigen
immunoassay
pediatr
subject
recent
advoc
sampl
approach
swab
throat
anterior
nare
singl
specimen
recent
studi
show
excel
sensit
pcr
influenza
viru
rsv
perform
combin
nosethroat
specimen
parentcollect
respiratori
swab
util
research
studi
shown
yield
sensit
equival
healthcar
workercollect
swab
combin
pcr
test
practic
limit
parentor
patientcollect
swab
avail
viral
transport
medium
howev
recent
studi
show
viral
rna
stabl
dri
respiratori
swab
swab
sensit
tradit
collect
respiratori
specimen
detect
virus
nucleic
acid
sequencebas
amplif
nasba
rapid
immunoassay
provid
result
point
care
less
minut
rapid
immunoassay
wide
use
detect
influenza
virus
rsv
rapid
immunoassay
format
includ
membranebas
enzym
immunoassay
later
flow
immunochromatographi
optic
immunoassay
test
result
read
manual
eye
although
one
test
includ
autom
reader
sensit
rapid
rsv
immunoassay
pediatr
patient
gener
higher
cell
cultur
due
labil
rsv
sensit
rapid
immunoassay
also
depend
studi
popul
children
often
shed
respiratori
virus
higher
titer
longer
time
period
adult
spite
poor
sensit
test
detect
influenza
viru
posit
result
emerg
set
hospit
patient
significantli
impact
patient
manag
recent
evalu
rapid
immunoassay
detect
novel
influenza
viru
demonstr
variabl
gener
poor
sensit
case
lower
compar
revers
transcriptas
rt
pcr
data
highlight
limit
diagnost
test
target
infecti
agent
influenza
viru
capabl
evolv
significantli
rapidli
test
direct
fluoresc
antibodi
dfa
stain
viral
antigen
patient
specimen
gener
consid
sensit
rapid
immunoassay
specif
dfa
high
depend
experienc
technologist
food
drug
administr
fda
clear
commerci
dfa
reagent
long
avail
detect
identif
influenza
b
virus
rsv
parainfluenza
virus
adenoviru
recent
advanc
dfa
test
includ
avail
fdaclear
commerci
dfa
reagent
detect
human
metapneumoviru
studi
show
excel
sensit
versu
rtpcr
human
metapneumoviru
dfa
perform
nasopharyng
aspir
children
dfa
substanti
sensit
rapid
immunoassay
detect
novel
influenza
viru
though
less
sensit
viru
isol
andor
rtpcr
long
consid
gold
standard
detect
respiratori
virus
turnaround
time
convent
cell
cultur
tube
respiratori
virus
gener
long
clinic
relev
perform
fresh
specimen
maintain
refriger
temperatur
viru
isol
excel
sensit
respiratori
virus
use
centrifugationenhanc
shell
vial
cultur
mix
cell
line
vial
decreas
turnaround
time
hour
streamlin
workflow
studi
show
shell
vial
contain
mix
cell
line
similar
sensit
convent
tube
cultur
detect
influenza
parainfluenza
virus
rsv
detect
shell
vial
system
sensit
convent
cultur
less
sensit
direct
antigen
test
viru
isol
shell
vial
highli
sensit
detect
influenza
diagnost
util
serolog
gener
limit
need
collect
acut
convalesc
sera
identifi
either
seroconvers
fourfold
rise
antibodi
titer
serolog
method
detect
igg
respons
usual
littl
impact
patient
manag
test
detect
igm
antibodi
detect
acut
infect
sensit
reduc
serum
igm
level
often
low
due
repeat
exposur
vaccin
circul
viru
recent
advanc
serolog
assay
respiratori
virus
larg
limit
novel
microagglutin
assay
detect
measur
antibodi
titer
novel
influenza
viru
subtyp
assay
util
engin
report
virusesa
lentivir
vector
pseudotyp
contain
influenza
hemagglutinin
protein
elimin
need
enhanc
biocontain
facil
pseudotyp
lentivir
particl
express
hemagglutinin
protein
replic
defici
microneutr
assay
employ
either
infecti
noninfecti
report
virus
perform
primarili
retrospect
studi
epidemiolog
survey
vaccin
trial
limit
implic
routin
diagnost
nucleic
acid
amplif
method
rtpcr
nucleic
acid
sequencebas
amplif
nasba
becom
commonli
use
detect
influenza
viru
respiratori
virus
use
realtim
fluoresc
detect
amplifi
product
laboratori
abl
perform
molecular
test
less
hour
high
specif
requir
judici
select
primer
probe
optim
amplif
condit
interpret
result
continu
adher
laboratori
protocol
essenti
avoid
fals
posit
due
carryov
contamin
due
limit
number
cost
fdaclear
nucleic
acid
amplif
test
mani
laboratori
perform
test
develop
verifi
hous
refer
laboratorydevelop
test
ldt
ldt
laboratoryverifi
commerci
kit
viabl
option
detect
common
respiratori
virus
rsv
well
virus
fdaclear
commerci
assay
avail
human
bocaviru
develop
verif
ldt
requir
consider
resourc
expertis
well
perform
characterist
ldt
may
vari
significantli
laboratori
consensu
recommend
verif
qualiti
assur
laboratori
test
includ
ldt
avail
realtim
pcr
amplif
detect
increas
fluoresc
analysi
occur
simultan
realtim
pcr
well
suit
quantit
analysi
current
avail
commerci
kit
detect
respiratori
viru
nucleic
acid
qualit
claim
realtim
pcr
instrument
limit
number
emiss
channel
avail
multiplex
result
commerci
avail
multiplex
realtim
pcr
kit
gener
limit
detect
four
fewer
nucleic
acid
target
one
target
usual
intern
control
fdaclear
realtim
rtpcr
assay
current
avail
detect
influenza
includ
subtyp
influenza
b
virus
rsv
parainfluenza
virus
human
metapneumoviru
studi
demonstr
molecular
amplif
method
includ
realtim
rtpcr
provid
sensit
detect
respiratori
virus
convent
pcr
requir
postamplif
detect
pcr
product
eg
via
sequencespecif
dna
probe
electrophoresi
either
format
allow
highli
multiplex
assay
abl
detect
pathogen
singl
pcr
reaction
realtim
pcr
fdaclear
assay
util
convent
rtpcr
microarray
sequencespecif
bead
detect
rsv
influenza
includ
subtyp
influenza
b
virus
parainfluenza
virus
human
metapneumoviru
rhinovirus
adenovirus
singl
rtpcr
reaction
pcr
assay
format
provid
sensit
detect
influenza
virus
well
abil
detect
broad
scope
respiratori
pathogen
high
sensit
molecular
amplif
test
made
interpret
posit
result
challeng
assay
detect
respiratori
viru
nucleic
acid
absenc
symptom
also
indic
nucleic
acid
persist
follow
infect
addit
method
frequent
detect
multipl
pathogen
specimen
addit
studi
need
fulli
understand
clinic
signific
data
well
etiolog
role
newli
discov
agent
human
bocaviru
quantit
realtim
pcr
method
proven
use
regard
past
sever
year
wit
explos
improv
respiratori
viru
diagnost
novel
specimen
collect
instrument
highli
sensit
multiplex
nucleic
acid
amplif
test
expand
list
antigen
molecularbas
test
possibl
laboratori
offer
comprehens
test
respiratori
virus
without
even
perform
viru
isol
howev
cell
cultur
still
remain
gold
standard
mani
laboratori
recent
advanc
also
made
tradit
approach
improv
turnaround
time
use
combin
shell
vial
cultur
immunostain
sensit
rapid
turnaround
time
nucleic
acid
amplif
technolog
pcr
like
focu
advanc
respiratori
viru
diagnost
futur
like
promis
addit
commerci
test
kit
molecular
detect
respiratori
virus
includ
multiplex
assay
exquisit
sensit
nucleic
acid
amplif
test
creat
diagnost
conundrum
addit
research
need
elucid
clinic
signific
posit
pcr
result
persist
patient
two
respiratori
virus
detect
singl
specimen
futur
research
respiratori
viru
diagnost
aim
toward
abil
accur
detect
spectrum
clinic
signific
virus
rapidli
enough
affect
patient
manag
initi
infect
control
measur
keep
cost
afford
commerci
kit
provid
standard
achiev
laboratorydevelop
test
substanti
higher
cost
ultim
util
molecular
test
particularli
highli
multiplex
test
routin
patient
manag
depend
costbenefit
ratio
current
futur
diagnost
option
includ
antigen
molecular
culturebas
method
perform
characterist
limit
method
vari
greatli
new
gener
assay
import
diagnost
virologist
clinician
understand
characterist
limit
